BBWI
Bath & Body Works, Inc. NYSE$19.21
After hrs
$18.56
-0.05%
Mkt Cap $4.1B
52w Low $14.28
24.2% of range
52w High $34.66
50d MA $20.10
200d MA $23.57
P/E (TTM)
6.3x
EV/EBITDA
6.2x
P/B
—
Debt/Equity
-3.9x
ROE
-50.7%
P/FCF
5.3x
RSI (14)
—
ATR (14)
—
Beta
1.46
50d MA
$20.10
200d MA
$23.57
Avg Volume
5.8M
About
Bath & Body Works, Inc. operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. The company sells its products under the Bath & Body Works, White Barn, and other brand names through specialty retail stores and websites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale a…
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | 1M% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 4, 2026 | AMC | 1.77 | 2.05 | +15.8% | 23.01 | +1.5% | -3.1% | -9.6% | -6.0% | -11.2% | -12.9% | -21.3% | — |
| Nov 20, 2025 | AMC | 0.38 | 0.35 | -8.4% | 15.82 | -3.3% | -6.1% | -1.6% | +6.8% | +9.8% | +10.1% | +21.9% | — |
| Aug 28, 2025 | AMC | 0.37 | 0.37 | +0.0% | 29.36 | -0.2% | -0.5% | +0.7% | +4.1% | +8.5% | +0.2% | -11.2% | — |
| May 29, 2025 | AMC | 0.42 | 0.49 | +17.3% | 28.58 | -0.6% | -1.6% | -6.5% | -5.0% | -5.4% | -7.0% | +4.8% | — |
| Feb 27, 2025 | AMC | 2.04 | 2.09 | +2.5% | 35.86 | +0.0% | +1.0% | -1.5% | -4.5% | -3.5% | -4.6% | -15.4% | — |
| Nov 25, 2024 | AMC | 0.47 | 0.49 | +4.3% | 35.78 | +0.3% | -1.5% | +0.3% | +1.3% | +4.8% | +3.1% | +6.8% | — |
| Aug 28, 2024 | AMC | 0.36 | 0.37 | +3.9% | 32.29 | +0.6% | -4.0% | -4.7% | -5.6% | -8.6% | -8.9% | +0.3% | — |
| Jun 4, 2024 | AMC | 0.33 | 0.38 | +15.2% | 45.17 | +0.3% | +4.5% | +2.7% | +1.5% | +1.0% | -1.0% | -18.1% | — |
| Feb 29, 2024 | AMC | 1.87 | 2.06 | +10.2% | 45.70 | -1.3% | -0.0% | -0.1% | -1.3% | -2.0% | -4.2% | +9.9% | — |
| Nov 16, 2023 | AMC | 0.35 | 0.48 | +37.1% | 30.10 | +1.3% | -2.5% | -3.5% | -1.4% | -1.6% | -0.2% | +37.7% | — |
Recent Analyst Ratings
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 5 | Barclays | Maintains | Equal Weight → Equal Weight | — | $23.01 | $23.36 | +1.5% | -3.1% | -9.6% | -6.0% | -11.2% | -12.9% |
| Mar 5 | Telsey Advisory Group | Maintains | Market Perform → Market Perform | — | $23.01 | $23.36 | +1.5% | -3.1% | -9.6% | -6.0% | -11.2% | -12.9% |
| Mar 4 | Telsey Advisory Group | Maintains | Market Perform → Market Perform | — | $22.43 | $23.51 | +4.8% | +2.6% | -0.6% | -7.3% | -3.6% | -8.9% |
| Mar 2 | Barclays | Maintains | Equal Weight → Equal Weight | — | $22.76 | $22.06 | -3.1% | -3.2% | -1.4% | +1.1% | -2.1% | -8.6% |
| Feb 27 | Telsey Advisory Group | Maintains | Market Perform → Market Perform | — | $23.31 | $22.75 | -2.4% | -2.4% | -5.4% | -3.8% | -1.3% | -4.4% |
| Feb 23 | UBS | Maintains | Neutral → Neutral | — | $24.38 | $23.80 | -2.4% | -7.6% | -4.6% | -7.0% | -4.4% | -6.6% |
| Feb 17 | Citigroup | Downgrade | Buy → Neutral | — | $24.07 | $24.20 | +0.5% | +2.5% | -0.7% | +0.3% | +1.3% | -6.4% |
| Jan 8 | UBS | Maintains | Neutral → Neutral | — | $21.95 | $21.60 | -1.6% | +3.7% | +6.1% | +2.8% | +4.7% | +4.9% |
| Jan 6 | Barclays | Maintains | Equal Weight → Equal Weight | — | $20.23 | $20.25 | +0.1% | +8.9% | +8.5% | +12.6% | +15.1% | +11.6% |
| Nov 21 | Goldman Sachs | Downgrade | Buy → Neutral | — | $15.82 | $15.30 | -3.3% | -6.1% | -1.6% | +6.8% | +9.8% | +10.1% |
Recent Filings
8-K · 7.01
! Medium
Bath & Body Works, Inc. -- 8-K 7.01: Regulation FD Disclosure
Bath & Body Works disclosed material information to investors via Regulation FD, ensuring fair access to nonpublic information across the market simultaneously.
Mar 4
8-K · 7.01
! Medium
Bath & Body Works, Inc. -- 8-K 7.01: Regulation FD Disclosure
Bath & Body Works will redeem its Notes on April 10, 2026, signaling the company's intention to retire this debt obligation and potentially refinance or strengthen its balance sheet.
Mar 3
8-K
Bath & Body Works, Inc. -- 8-K Filing
Bath & Body Works CEO Wu's departure includes standard post-employment restrictions: perpetual confidentiality, one-year non-solicitation, and nine-month non-compete covenants protecting company interests.
Feb 25
Data updated apr 24, 2026 8:47pm
· Source: massive.com